Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2000 1
2001 1
2003 2
2004 4
2005 3
2006 8
2007 5
2008 2
2009 6
2010 11
2011 8
2012 6
2013 10
2014 6
2015 10
2016 8
2017 3
2018 5
2019 9
2020 3
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 31501181

102 results
Results by year
Filters applied: . Clear all
Page 1
Canadian guideline for Parkinson disease.
Grimes D, Fitzpatrick M, Gordon J, Miyasaki J, Fon EA, Schlossmacher M, Suchowersky O, Rajput A, Lafontaine AL, Mestre T, Appel-Cresswell S, Kalia SK, Schoffer K, Zurowski M, Postuma RB, Udow S, Fox S, Barbeau P, Hutton B. Grimes D, et al. CMAJ. 2019 Sep 9;191(36):E989-E1004. doi: 10.1503/cmaj.181504. CMAJ. 2019. PMID: 31501181 Free PMC article. No abstract available.
New and emerging treatments for Parkinson disease.
Fung VS. Fung VS. Med J Aust. 2015 Apr 6;202(6):283-4. doi: 10.5694/mja15.00155. Med J Aust. 2015. PMID: 25832138 No abstract available.
Diagnosis and Treatment of Parkinson Disease: A Review.
Armstrong MJ, Okun MS. Armstrong MJ, et al. JAMA. 2020 Feb 11;323(6):548-560. doi: 10.1001/jama.2019.22360. JAMA. 2020. PMID: 32044947 Review.
In a rush to decide: deep brain stimulation and dopamine agonist therapy in Parkinson's disease.
Djamshidian A, O'Sullivan SS, Tomassini A, Foltynie T, Limousin P, Aviles-Olmos I, Warner TT, Lees AJ, Averbeck BB. Djamshidian A, et al. J Parkinsons Dis. 2014;4(4):579-83. doi: 10.3233/JPD-140388. J Parkinsons Dis. 2014. PMID: 25061059 Free PMC article.
Decision-making under risk is improved by both dopaminergic medication and subthalamic stimulation in Parkinson's disease.
Boller JK, Barbe MT, Pauls KA, Reck C, Brand M, Maier F, Fink GR, Timmermann L, Kalbe E. Boller JK, et al. Exp Neurol. 2014 Apr;254:70-7. doi: 10.1016/j.expneurol.2014.01.005. Epub 2014 Jan 18. Exp Neurol. 2014. PMID: 24444545 Clinical Trial.
Current and experimental treatments of Parkinson disease: A guide for neuroscientists.
Oertel W, Schulz JB. Oertel W, et al. J Neurochem. 2016 Oct;139 Suppl 1:325-337. doi: 10.1111/jnc.13750. Epub 2016 Aug 30. J Neurochem. 2016. PMID: 27577098 Free article. Review.
Choosing an Advanced Therapy in Parkinson's Disease; is it an Evidence-Based Decision in Current Practice?
Nijhuis FA, van Heek J, Bloem BR, Post B, Faber MJ. Nijhuis FA, et al. J Parkinsons Dis. 2016 Jul 25;6(3):533-43. doi: 10.3233/JPD-160816. J Parkinsons Dis. 2016. PMID: 27472888
[Parkinson's disease on the advance].
Ceballos-Baumann A. Ceballos-Baumann A. MMW Fortschr Med. 2009 Mar 26;151(13):61-4. MMW Fortschr Med. 2009. PMID: 19504822 German. No abstract available.
Quantitative measurements of alternating finger tapping in Parkinson's disease correlate with UPDRS motor disability and reveal the improvement in fine motor control from medication and deep brain stimulation.
Taylor Tavares AL, Jefferis GS, Koop M, Hill BC, Hastie T, Heit G, Bronte-Stewart HM. Taylor Tavares AL, et al. Mov Disord. 2005 Oct;20(10):1286-98. doi: 10.1002/mds.20556. Mov Disord. 2005. PMID: 16001401
Dopaminergic dose adjustment and negative affective symptoms after deep brain stimulation.
Tareen TK, Artusi CA, Rodriguez-Porcel F, Devoto JL, Sheikh H, Mandybur GT, Duker AP, Espay AJ, Merola A. Tareen TK, et al. J Neurol Sci. 2018 Jul 15;390:33-35. doi: 10.1016/j.jns.2018.04.002. Epub 2018 Apr 7. J Neurol Sci. 2018. PMID: 29801902 No abstract available.
102 results
Jump to page
Feedback